Data last refreshed 45 days ago — analysis may not reflect the latest market data

Intellia Therapeutics, Inc.NTLA

NASDAQ • Healthcare

—

$14.20

P/E

—

PEG

—

FCF Yield

—

Rev Growth YoY

-9.5% YoY

Gross Margin

85.4%

Health Score

—

D/E Ratio

0.14

Confidence

—

Business Snapshot

Business snapshot content not available.

Financial Health

Risk Assessment

Metric deep-dives

EV/EBITDA→FCF Yield→Revenue Growth→Gross Margin→Return on Equity (ROE)→Debt-to-Equity→Current Ratio→Quick Ratio→

Last updated 1084 hours ago · Data sourced from FMP & Finnhub · Not financial advice